Curative treatments, including liver transplantation, surgical resection and percutaneous
treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or …

Locoregional therapies can be offered to hepatocellular carcinoma patients as a bridge to
transplant, to downstage disease burden for transplant eligibility, or for disease control to …

Hepatocellular carcinoma (HCC) is the fifth most common form of human cancer worldwide
and the third most common cause of cancer-related deaths. The strategies of various …

Background: Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and
the second most lethal malignancy worldwide. In the Western world, HCC predominantly …

Hepatocellular carcinoma (HCC) represents one of the most common neoplasms worldwide.
To date, curative treatment options include liver transplantation or resection. Unfortunately …

Background Hepatocellular carcinoma (HCC) remains one of the most common neoplasms
worldwide. Curative treatment options include liver transplantation or resection …

Hepatocellular carcinoma (HCC) is the third most frequent cause of death from cancer with
an increasing incidence in the world. Hepatic cirrhosis is the main risk factor for the …

Hepatocellular carcinoma (HCC) offers unique management challenges as it commonly
occurs in the setting of underlying chronic liver disease. The management of HCC is …

Hepatocellular carcinoma is one of the most frequent tumors worldwide, and its frequency is
increasing. The management of hepatocellular carcinoma has changed in recent years, this …

The management of hepatocellular carcinoma (HCC) is decided according to evidence‐
based recommendations generated by international societies: according to these …